Literature DB >> 21576536

Interpretation of subgroup analyses in randomized trials: heterogeneity versus secondary interventions.

Tyler J VanderWeele1, Mirjam J Knol.   

Abstract

In randomized trials with subgroup analyses, the primary treatment or intervention of interest is randomized, but the secondary factors defining subgroups are not. This article clarifies when confounding is an issue in subgroup analyses. If investigators are interested simply in targeting subpopulations for intervention, control for confounding is not needed. If investigators are interested in intervening on the secondary factors that define the subgroups to increase the treatment effect or in attributing the subgroup differences to the secondary factors themselves, then confounding is relevant and must be controlled for. The authors demonstrate this point by using examples from published randomized trials.

Entities:  

Mesh:

Year:  2011        PMID: 21576536      PMCID: PMC3825512          DOI: 10.7326/0003-4819-154-10-201105170-00008

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  16 in total

1.  Confidence interval estimation of interaction.

Authors:  D W Hosmer; S Lemeshow
Journal:  Epidemiology       Date:  1992-09       Impact factor: 4.822

2.  Treating individuals 2. Subgroup analysis in randomised controlled trials: importance, indications, and interpretation.

Authors:  Peter M Rothwell
Journal:  Lancet       Date:  2005 Jan 8-14       Impact factor: 79.321

3.  Calculating measures of biological interaction.

Authors:  Tomas Andersson; Lars Alfredsson; Henrik Källberg; Slobodan Zdravkovic; Anders Ahlbom
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

4.  The challenge of subgroup analyses--reporting without distorting.

Authors:  Stephen W Lagakos
Journal:  N Engl J Med       Date:  2006-04-20       Impact factor: 91.245

5.  Statistics in medicine--reporting of subgroup analyses in clinical trials.

Authors:  Rui Wang; Stephen W Lagakos; James H Ware; David J Hunter; Jeffrey M Drazen
Journal:  N Engl J Med       Date:  2007-11-22       Impact factor: 91.245

6.  Confounding of subgroup analyses in randomized data.

Authors:  Rolf H H Groenwold; A Rogier T Donders; Geert J M G van der Heijden; Arno W Hoes; Maroeska M Rovers
Journal:  Arch Intern Med       Date:  2009-09-14

7.  On the distinction between interaction and effect modification.

Authors:  Tyler J VanderWeele
Journal:  Epidemiology       Date:  2009-11       Impact factor: 4.822

8.  Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials.

Authors:  S Yusuf; J Wittes; J Probstfield; H A Tyroler
Journal:  JAMA       Date:  1991-07-03       Impact factor: 56.272

9.  A 4-year trial of tiotropium in chronic obstructive pulmonary disease.

Authors:  Donald P Tashkin; Bartolome Celli; Stephen Senn; Deborah Burkhart; Steven Kesten; Shailendra Menjoge; Marc Decramer
Journal:  N Engl J Med       Date:  2008-10-05       Impact factor: 91.245

10.  Effect of a housing and case management program on emergency department visits and hospitalizations among chronically ill homeless adults: a randomized trial.

Authors:  Laura S Sadowski; Romina A Kee; Tyler J VanderWeele; David Buchanan
Journal:  JAMA       Date:  2009-05-06       Impact factor: 56.272

View more
  43 in total

1.  Recommendations for presenting analyses of effect modification and interaction.

Authors:  Mirjam J Knol; Tyler J VanderWeele
Journal:  Int J Epidemiol       Date:  2012-01-09       Impact factor: 7.196

2.  Sample Size and Power Calculations for Additive Interactions.

Authors:  T J VanderWeele
Journal:  Epidemiol Methods       Date:  2012-08-01

3.  Targeting weight loss interventions to reduce cardiovascular complications of type 2 diabetes: a machine learning-based post-hoc analysis of heterogeneous treatment effects in the Look AHEAD trial.

Authors:  Aaron Baum; Joseph Scarpa; Emilie Bruzelius; Ronald Tamler; Sanjay Basu; James Faghmous
Journal:  Lancet Diabetes Endocrinol       Date:  2017-07-12       Impact factor: 32.069

4.  The table 2 fallacy: presenting and interpreting confounder and modifier coefficients.

Authors:  Daniel Westreich; Sander Greenland
Journal:  Am J Epidemiol       Date:  2013-01-30       Impact factor: 4.897

5.  Invited commentary: assessing mechanistic interaction between coinfecting pathogens for diarrheal disease.

Authors:  Tyler J Vanderweele
Journal:  Am J Epidemiol       Date:  2012-07-25       Impact factor: 4.897

6.  Detecting moderator effects using subgroup analyses.

Authors:  Rui Wang; James H Ware
Journal:  Prev Sci       Date:  2013-04

7.  How subgroup analyses can miss the trees for the forest plots: A simulation study.

Authors:  Michael Webster-Clark; John A Baron; Michele Jonsson Funk; Daniel Westreich
Journal:  J Clin Epidemiol       Date:  2020-06-19       Impact factor: 6.437

8.  Economic inequalities in the effectiveness of a primary care intervention for depression and suicidal ideation.

Authors:  Stephen E Gilman; Garrett M Fitzmaurice; Martha L Bruce; Thomas Ten Have; M Maria Glymour; Hannah Carliner; George S Alexopoulos; Benoit H Mulsant; Charles F Reynolds; Alex Cohen
Journal:  Epidemiology       Date:  2013-01       Impact factor: 4.822

9.  The use of relative incidence ratios in self-controlled case series studies: an overview.

Authors:  Steven Hawken; Beth K Potter; Julian Little; Eric I Benchimol; Salah Mahmud; Robin Ducharme; Kumanan Wilson
Journal:  BMC Med Res Methodol       Date:  2016-09-23       Impact factor: 4.615

10.  Attributing effects to interactions.

Authors:  Tyler J VanderWeele; Eric J Tchetgen Tchetgen
Journal:  Epidemiology       Date:  2014-09       Impact factor: 4.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.